Condition
Nerve Block; Pain Medication
Total Trials
2
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
4 treatments under study, led by Sham Injection In Pectineus Muscle
Related Conditions
Often studied with 6 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 2 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Completed1
Not Yet Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 1 completed trials
Clinical Trials (2)
Research Network
Common Treatments
- Sham Injection In Pectineus Muscle1
- Pectoral Nerve Block Pecs1
- Serratus Anterior Plane Block Sapb Group1
- Oburator Nerve Block1
Active Sponsors
- Trinity Health Of New England1
- Lebanese American University Medical Center1
- Lebanese American University1
Related Conditions
- Opioid Analgesic Adverse Reaction1
- Pectoralis Nerve Block1
- Serratus Anterior Muscle Plane Block1
- Mastectomy1
- Opioid Consumption1